The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: Data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Equils, Ozlem ^a   da Costa, Christopher ^a   Wible, Michele ^a   Lipsky, Benjamin A ^b,c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Diabetes mellitus; Infection; Linezolid; Mortality; MRSA; Outcome; Pneumonia; Prognosis; Staphylococcus; Vancomycin

Indexed keywords

HYPERTENSIVE FACTOR; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; END OF STUDY; END OF TREATMENT; ERYTHEMA; FEMALE; GENITAL RASH; HUMAN; INJECTION SITE REACTION; INTENTION TO TREAT ANALYSIS; KIDNEY DISEASE; MACULAR RASH; MACULO PAPULAR RASH; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MODIFIED INTENT TO TREAT; MORTALITY RATE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; NAUSEA; NOSOCOMIAL PNEUMONIA; PAPULAR RASH; PNEUMONIA; PUSTULAR RASH; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY ARREST; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SMOKING; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; AGED; CLINICAL TRIAL; DRUG EFFECTS; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; PROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DIABETES MELLITUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LINEZOLID; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84984973445     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1779-5     Document Type: Article

References (31)

1. Geerlings SE, Hoepelman AIM. Immune dysfunction in patients with diabetes. FEMS Immunol Med Microbiol. 2000;26:259-66.
2. Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus. Infect Dis Clin North Am. 1995;9:65-96.
3. Kabitz HJ, Sonntag F, Walker D, et al. Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes. Diabetologia. 2008;511:191-7.
4. van den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138:393-406.
5. Meyer E, Schwab F, Gastmeier P. Nosocomial methicillin resistant Staphylococcus aureus pneumonia - epidemiology and trends based on data of a network of 586 German ICUs (2005-2009). Eur J Med Res. 2010;15:514-24.
6. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906-12.
7. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281-8.
8. Niederman MS, Craven DE, Bonten MJ, American Thoracic Society, The Infectious Diseases Society of America, et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
9. Haque NZ, Arshad S, Peyrani P, Ford KD, Perri MB, Jacobsen G, Reyes K, Scerpella EG, Ramirez JA, Zervos MJ. Analysis of Pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant staphylococcus aureus. J Clin Microbiol. 2012;50:1640-4.
10. Wunderink RG. How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy? Infect Dis Clin North Am. 2013;27:177-88.
11. Peyrani P, Wiemken TL, Kelley R, Zervos MJ, Kett DH, File Jr TM, Stein GE, Ford KD, Scerpella EG, Welch V, Ramirez JA. IMPACT-HAP Study Group Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study. Crit Care. 2014;18:R118.
12. Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis. 2012;54:621-8.
13. Breen JD, Karchmer AW. Staphylococcus aureus infections in diabetic patients. Infect Dis Clin North Am. 1995;9:11-24.
14. McKinnell JA, Miller LG, Eells SJ, Cui E, Huang SS. A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol. 2013;34:1077-86.
15. Shorr AF, Myers DE, Huang DB, Nathanson BH, Emons MF, Kollef MH. A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis. 2013;13:268-79.
16. Chen CC, Pass SE. Risk factors for and impact of methicillin-resistant Staphylococcus aureus nasal colonization in patients in a medical intensive care unit. Am J Infect Control. 2013;41:1100-11.
17. Korol E, Johnston K, Waser N, Sifakis F, Jafri HS, Lo M, Kyaw MH. A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS One. 2013;8:e83743.
18. Lipsky BA, Itani KM, Weigelt JA, Joseph W, Paap CM, Reisman A, Myers DE, Huang DB. The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials. Int J Infect Dis. 2011;15:e140-6.
19. Haque NZ, Arshad S, Peyrani P, Ford KD, Perri MB, Jacobsen G, Reyes K, Scerpella EG, Ramirez JA, Zervos MJ. Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2012;50:1640-4.
20. Polverino E, Torres A. Current perspective of the HCAP problem: is it CAP or is it HAP? Semin Respir Crit Care Med. 2009;30:239-48.
21. Guo Y, Ramos RI, Cho JS, Donegan NP, Cheung AL, Miller LS. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Antimicrob Agents Chemother. 2013;57:855-63.
22. Burgess DS, Lewis 2nd JS. Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia. Clin Ther. 2000;22:872-8.
23. Kalil AC, Klompas M, Haynatzki G, Rupp ME. Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis. BMJ Open. 2013;3:e003912.
24. Lamer C, de Beco V, Soler P, Calvat S, Fagon JY, Dombret MC, Farinotti R, Chastre J, Gibert C. Analysis of Vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother. 1993;37:281-6.
25. Harigaya Y, Bulitta JB, Forrest A, Sakoulas G, Lesse AJ, Mylotte JM, Tsuji BT. Pharmacodynamics of Vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia. Antimicrob Agents Chemother. 2009;53:3894-901.
26. Martinez-Olondris P, Rigol M, Soy D, Guerrero L, Agusti C, Quera MA, Li Bassi G, Esperatti M, Luque N, Liapikou M, Filella X, Marco F, de la Bellacasa JP, Torres A. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs. Crit Care Med. 2012;40:162-8.
27. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis. 1979;120:973-83.
28. Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest. 2005;128:3233-9.
29. Kaasch AJ, Barlow G, Edgeworth JD, Fowler Jr VG, Hellmich M, Hopkins S, Kern WV, Llewelyn MJ, Rieg S, Rodriguez-Baño J, Scarborough M, Seifert H, Soriano A, Tilley R, Torok ME, Weiß V, Wilson AP, Thwaites GE, ISAC, INSTINCT, SABG, UKCIRG, Colleagues. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect. 2014;68:242-51.
30. Wiese L, Mejer N, Schønheyder HC, Westh H, Jensen AG, Larsen AR, Skov R, Benfield T, Danish Staphylococcal Bacteraemia Study Group. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia. J Infect. 2013;67:199-205.
31. Haldar S, Chia SC, Henry CJ. Body composition in asians and caucasians: comparative analyses and influences on cardiometabolic outcomes. Adv Food Nutr Res. 2015;75:97-154.